治疗性干预对重型创伤性脑损伤后脑自动调节功能的影响:BOOST-II研究的二次分析
本文为BOOST-II随机对照试验的二次分析,纳入55例同时记录动脉血压、颅内压和脑组织氧分压的重型创伤性脑损伤患者,用时间相关分析计算压力反应指数和氧反应指数,确定个体化最佳脑灌注压和自动调节界限。共识别35次脑组织缺氧(脑组织氧分压<20 mm Hg)并接受提高脑灌注压的干预,干预后平均脑组织氧分压从18.4±5.6 mm Hg升至21.9±5.6 mm Hg(p=0.01),平均脑灌注压从73±14 mm Hg升至79±17 mm Hg(p=0.15)。干预后60分钟内脑灌注压低于自动调节下限的时间百分比从23%降至11%(p=0.05),自动调节功能呈改善趋势但未达统计学显著。作者认为脑组织缺氧与脑灌注不足相关,提高脑灌注压的干预似乎改善自动调节功能,需进一步研究验证自动调节作为可干预变量改善预后的重要性。
要点
- 55例重型创伤性脑损伤患者中识别35次脑组织缺氧(脑组织氧分压<20 mm Hg)并接受提高脑灌注压的干预。
- 干预后平均脑组织氧分压从18.4±5.6 mm Hg升至21.9±5.6 mm Hg(p=0.01),平均脑灌注压从73±14 mm Hg升至79±17 mm Hg(p=0.15)。
- 干预后60分钟内脑灌注压低于自动调节下限的时间百分比从23%降至11%(p=0.05)。
- 氧反应指数0.42 vs 0.37(p=0.14)、压力反应指数0.25 vs 0.21(p=0.2)呈改善趋势但未达统计学显著。
- 作者认为脑组织缺氧与脑灌注不足相关,提高脑灌注压的干预似乎改善自动调节功能,需进一步研究验证。
适用人群与场景
- BOOST-II随机对照试验纳入的119例重型创伤性脑损伤患者中,55例有动脉血压、颅内压和脑组织氧分压同步记录者进入本二次分析。
- 平均年龄38岁,平均监测时间92 h。
诊断标准与关键阈值
- 脑组织缺氧定义为脑组织氧分压<20 mm Hg。
- 通过时间相关分析计算压力反应指数和氧反应指数,确定个体化最佳脑灌注压和自动调节界限。
处置流程与药物剂量
- 对脑组织缺氧(脑组织氧分压<20 mm Hg) episodes 采取提高脑灌注压的干预,共35次。
- 干预后平均脑灌注压从73±14 mm Hg升至79±17 mm Hg(p=0.15)。
研究设计与关键结果
- 二次分析纳入55例患者(平均年龄38岁,平均监测时间92 h),识别35次脑组织缺氧(脑组织氧分压<20 mm Hg)并接受脑灌注压提高干预。
- 干预后平均脑灌注压从73±14 mm Hg升至79±17 mm Hg(p=0.15),平均脑组织氧分压从18.4±5.6 mm Hg升至21.9±5.6 mm Hg(p=0.01)。
- 自动调节功能呈改善趋势:氧反应指数0.42 vs 0.37(p=0.14),压力反应指数0.25 vs 0.21(p=0.2)。
- 最佳脑灌注压和自动调节界限相对不变,但干预后60分钟内脑灌注压低于自动调节下限的时间百分比从23%降至11%(p=0.05)。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脑组织缺氧与脑灌注不足相关,后者以脑灌注压低于自动调节下限时间增加为特征。
- 作者认为提高脑灌注压的干预似乎改善自动调节功能。
- 作者建议需进一步研究验证自动调节作为可干预变量改善预后的重要性。
指南或共识出处
- BOOST-II研究(Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase II随机对照试验)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase II randomized controlled trial used a tier-based management protocol based on brain tissue oxygen (PbtO2) and intracranial pressure (ICP) monitoring to reduce brain tissue hypoxia after severe traumatic brain injury. We performed a secondary analysis to explore the relationship between brain tissue hypoxia, blood pressure (BP), and interventions to improve cerebral perfusion pressure (CPP). We hypothesized that BP management below the lower limit of autoregulation would lead to cerebral hypoperfusion and brain tissue hypoxia that could be improved with hemodynamic augmentation.
METHODS: Of the 119 patients enrolled in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase II trial, 55 patients had simultaneous recordings of arterial BP, ICP, and PbtO2. Autoregulatory function was measured by interrogating changes in ICP and PbtO2 in response to fluctuations in CPP using time-correlation analysis. The resulting autoregulatory indices (pressure reactivity index and oxygen reactivity index) were used to identify the "optimal" CPP and limits of autoregulation for each patient. Autoregulatory function and percent time with CPP outside personalized limits of autoregulation were calculated before, during, and after all interventions directed to optimize CPP.
RESULTS: Individualized limits of autoregulation were computed in 55 patients (mean age 38 years, mean monitoring time 92 h). We identified 35 episodes of brain tissue hypoxia (PbtO2 < 20 mm Hg) treated with CPP augmentation. Following each intervention, mean CPP increased from 73 ± 14 mm Hg to 79 ± 17 mm Hg (p = 0.15), and mean PbtO2 improved from 18.4 ± 5.6 mm Hg to 21.9 ± 5.6 mm Hg (p = 0.01), whereas autoregulatory function trended toward improvement (oxygen reactivity index 0.42 vs. 0.37, p = 0.14; pressure reactivity index 0.25 vs. 0.21, p = 0.2). Although optimal CPP and limits remained relatively unchanged, there was a significant decrease in the percent time with CPP below the lower limit of autoregulation in the 60 min after compared with before an intervention (11% vs. 23%, p = 0.05).
CONCLUSIONS: Our analysis suggests that brain tissue hypoxia is associated with cerebral hypoperfusion characterized by increased time with CPP below the lower limit of autoregulation. Interventions to increase CPP appear to improve autoregulation. Further studies are needed to validate the importance of autoregulation as a modifiable variable with the potential to improve outcomes.
参考来源
- Prasad A, Gilmore EJ, Kim JA, et al. Impact of Therapeutic Interventions on Cerebral Autoregulatory Function Following Severe Traumatic Brain Injury: A Secondary Analysis of the BOOST-II Study. Neurocrit Care. 2023. PMID: 38158481. doi:10.1007/s12028-023-01896-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。